BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4069366)

  • 1. Complement-dependent lysis of cultured rat myotubes by myasthenic immunoglobulins.
    Ashizawa T; Appel SH
    Neurology; 1985 Dec; 35(12):1748-53. PubMed ID: 4069366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-dependent toxicity of serum from myasthenic patients to muscle cells in culture.
    Childs LA; Harrison R; Lunt GG
    J Neuroimmunol; 1985 Jul; 9(1-2):69-80. PubMed ID: 4008638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenic patients' IgG causes redistribution of acetylcholine receptors: freeze-fracture studies.
    Pumplin DW; Drachman DB
    J Neurosci; 1983 Mar; 3(3):576-84. PubMed ID: 6827310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes.
    Ashizawa T; Elias SB; Appel SH
    Ann Neurol; 1982 Jan; 11(1):22-7. PubMed ID: 6277235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process.
    Drachman DB; Angus CW; Adams RN; Kao I
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3422-6. PubMed ID: 277944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation.
    Kao I; Drachman DB
    Science; 1977 Apr; 196(4289):527-9. PubMed ID: 850793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
    Appel SH; Anwyl R; McAdams MW; Elias S
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2130-4. PubMed ID: 266734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis serum reduces acetylcholine sensitivity in cultured rat myotubes.
    Anwyl R; Appel SM; Narahashi T
    Nature; 1977 May; 267(5608):262-3. PubMed ID: 865618
    [No Abstract]   [Full Text] [Related]  

  • 10. Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture.
    Bevan S; Kullberg RW; Heinemann SF
    Nature; 1977 May; 267(5608):263-5. PubMed ID: 865619
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody-induced degradation of acetylcholine receptor in myasthenia gravis: clinical correlates and pathogenetic significance.
    Tronconi BC; Brigonzi A; Fumagalli G; Sher M; Cosi V; Piccolo G; Clementi F
    Neurology; 1981 Nov; 31(11):1440-4. PubMed ID: 7198191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
    Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of beta-cytoplasmic actin with high concentrations of acetylcholine receptor (AChR) in normal and anti-AChR-treated primary rat muscle cultures.
    Lubit BW
    J Histochem Cytochem; 1984 Sep; 32(9):973-81. PubMed ID: 6379042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis. Identification of skeletal and heart muscle antigens not related to the acetylcholine receptor.
    Mehl VS; Lang RW
    J Neuroimmunol; 1984 Aug; 6(5):347-60. PubMed ID: 6205020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6.
    Biesecker G; Gomez CM
    J Immunol; 1989 Apr; 142(8):2654-9. PubMed ID: 2703710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.
    Kaplan I; Blakely BT; Pavlath GK; Travis M; Blau HM
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8100-4. PubMed ID: 2236023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of myasthenic immunoglobulin on ACh receptors of cultured muscle.
    Drachman DB; Kao L; Angus CW; Murphy A
    Trans Am Neurol Assoc; 1977; 102():96-100. PubMed ID: 616125
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of myasthenic immunoglobulin G on motor end-plate morphology.
    Tsujihata M; Satoh A; Yoshimura T; Motomura M; Takeo G; Matsuo H; Nakamura T
    J Neurol; 2003 Jan; 250(1):75-82. PubMed ID: 12527996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in acetylcholine-receptor content of human myotube cultures mediated by monoclonal antibodies to alpha, beta and gamma subunits.
    Tzartos SJ; Starzinski-Powitz A
    FEBS Lett; 1986 Feb; 196(1):91-5. PubMed ID: 2417888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.